Encompass Health [EHC] vs Ensign Group [ENSG] Detailed Stock Comparison
Encompass Health
NYSE
Loading...
Ensign Group
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Encompass Health wins in 15 metrics, Ensign Group wins in 5 metrics, with 0 ties. Encompass Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Encompass Health | Ensign Group | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.92 | 28.84 | Encompass Health |
| Price-to-Book Ratio | 5.20 | 4.56 | Ensign Group |
| Debt-to-Equity Ratio | 86.97 | 100.93 | Encompass Health |
| PEG Ratio | 24.60 | 26.16 | Encompass Health |
| EV/EBITDA | 11.88 | 22.09 | Encompass Health |
| Profit Margin (TTM) | 9.22% | 7.00% | Encompass Health |
| Operating Margin (TTM) | 17.77% | 8.46% | Encompass Health |
| EBITDA Margin (TTM) | 17.77% | 8.46% | Encompass Health |
| Return on Equity | 24.72% | 17.54% | Encompass Health |
| Return on Assets (TTM) | 9.18% | 5.30% | Encompass Health |
| Free Cash Flow (TTM) | $360.30M | $188.95M | Encompass Health |
| Dividend Yield | 0.55% | 0.20% | Encompass Health |
| 1-Year Return | 37.17% | 13.72% | Encompass Health |
| Price-to-Sales Ratio (TTM) | 2.09 | 2.01 | Ensign Group |
| Enterprise Value | $15.24B | $10.83B | Encompass Health |
| EV/Revenue Ratio | 2.69 | 2.35 | Ensign Group |
| Gross Profit Margin (TTM) | 43.01% | 16.19% | Encompass Health |
| Revenue per Share (TTM) | $57 | $81 | Ensign Group |
| Earnings per Share (Diluted) | $5.13 | $5.57 | Ensign Group |
| Beta (Stock Volatility) | 0.74 | 1.02 | Encompass Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Encompass Health vs Ensign Group Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Encompass Health | 0.92% | 8.34% | -0.47% | 1.44% | 19.21% | 28.01% |
| Ensign Group | 0.86% | 5.85% | 10.15% | 17.87% | 24.30% | 20.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Encompass Health | 37.17% | 118.47% | 133.94% | 226.88% | 757.00% | 442.34% |
| Ensign Group | 13.72% | 82.87% | 189.21% | 609.18% | 3,477.51% | 3,798.79% |
Performance & Financial Health Analysis: Encompass Health vs Ensign Group
| Metric | EHC | ENSG |
|---|---|---|
| Market Information | ||
| Market Cap | $11.84B | $9.27B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,143,870 | 494,640 |
| 90 Day Avg. Volume | 1,073,713 | 440,357 |
| Last Close | $117.58 | $160.63 |
| 52 Week Range | $85.21 - $123.13 | $118.73 - $162.05 |
| % from 52W High | -4.51% | -0.88% |
| All-Time High | $123.13 (Jun 04, 2025) | $162.05 (Aug 08, 2025) |
| % from All-Time High | -4.51% | -0.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.19% |
| Quarterly Earnings Growth | 0.25% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.07% |
| Operating Margin (TTM) | 0.18% | 0.08% |
| Return on Equity (TTM) | 0.25% | 0.18% |
| Debt to Equity (MRQ) | 86.97 | 100.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.60 | $35.23 |
| Cash per Share (MRQ) | $0.98 | $7.30 |
| Operating Cash Flow (TTM) | $1.11B | $462.89M |
| Levered Free Cash Flow (TTM) | $261.28M | $30.01M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.55% | 0.20% |
| Last 12-Month Dividend | $0.66 | $0.30 |
Valuation & Enterprise Metrics Analysis: Encompass Health vs Ensign Group
| Metric | EHC | ENSG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.92 | 28.84 |
| Forward P/E | 24.60 | 26.16 |
| PEG Ratio | 24.60 | 26.16 |
| Price to Sales (TTM) | 2.09 | 2.01 |
| Price to Book (MRQ) | 5.20 | 4.56 |
| Market Capitalization | ||
| Market Capitalization | $11.84B | $9.27B |
| Enterprise Value | $15.24B | $10.83B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.69 | 2.35 |
| Enterprise to EBITDA | 11.88 | 22.09 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 1.02 |
| Book Value per Share (MRQ) | $22.60 | $35.23 |
Financial Statements Comparison: Encompass Health vs Ensign Group
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EHC | ENSG |
|---|---|---|
| Revenue/Sales | $1.46B | $1.23B |
| Cost of Goods Sold | $824.50M | $1.03B |
| Gross Profit | $630.90M | $198.79M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $267.00M | $103.90M |
| EBITDA | $349.60M | $140.17M |
| Pre-Tax Income | $238.60M | $112.36M |
| Income Tax | $41.60M | $27.89M |
| Net Income (Profit) | $196.50M | $84.47M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EHC | ENSG |
|---|---|---|
| Cash & Equivalents | $95.80M | $282.67M |
| Total Current Assets | $910.90M | $986.39M |
| Total Current Liabilities | $856.00M | $705.21M |
| Long-Term Debt | $2.54B | $1.91B |
| Total Shareholders Equity | $2.94B | $1.93B |
| Retained Earnings | $930.80M | $1.50B |
| Property, Plant & Equipment | $3.94B | $2.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EHC | ENSG |
|---|---|---|
| Operating Cash Flow | $289.30M | $97.90M |
| Capital Expenditures | $-163.10M | $-42.93M |
| Free Cash Flow | $125.50M | $29.29M |
| Debt Repayment | $-80.00M | $-1.01M |
| Common Stock Repurchase | $-32.10M | $-10.79M |
Short Interest & Institutional Ownership Analysis
| Metric | EHC | ENSG |
|---|---|---|
| Shares Short | 988,914 | 1.87M |
| Short Ratio | 1.08 | 5.73 |
| Short % of Float | 0.01% | 0.04% |
| Average Daily Volume (10 Day) | 1,143,870 | 494,640 |
| Average Daily Volume (90 Day) | 1,073,713 | 440,357 |
| Shares Outstanding | 100.78M | 57.44M |
| Float Shares | 99.34M | 55.24M |
| % Held by Insiders | 0.01% | 0.03% |
| % Held by Institutions | 0.97% | 0.95% |
Dividend Analysis & Yield Comparison: Encompass Health vs Ensign Group
| Metric | EHC | ENSG |
|---|---|---|
| Last 12-Month Dividend | $0.66 | $0.30 |
| Last 12-Month Dividend Yield | 0.55% | 0.20% |
| 3-Year Avg Annual Dividend | $3.68 | $0.26 |
| 3-Year Avg Dividend Yield | 1.66% | 0.05% |
| 3-Year Total Dividends | $11.04 | $0.78 |
| Ex-Dividend Date | Apr 01, 2025 | Jun 30, 2025 |